EASL Clinical Practice Guidelines on the management of hepatitis B virus infection

Clinical guideline · Tier 2, Specialist societies · EU · 2025

Current — checked with the publisher on 2026-09-01

DOI 10.1016/j.jhep.2025.03.018

https://www.journal-of-hepatology.eu/article/S0168-8278(25)00174-6/fulltext

Nothing has been drawn from it

This source is verified, correctly cited and unread: no claim on this platform derives from it. It appears in the ledger because its existence, publisher, date and currency have been confirmed — not because anything here rests on it.

How this record was checked, and what is doubtful about it

Located in Phase 12. Includes HCC surveillance in HBV — the group NICE NG50 carves out of its own surveillance recommendation (CLM-SUR-0003).

Verification: verified · last accessed 2026-09-01 · status checked against https://easl.eu/publications/clinical-practice-guidelines/